H.R. 4110 · 117th Congress
Reducing Hereditary Cancer Act of 2021
- Stage
- In committee
- Sponsor
- Debbie Wasserman Schultz
- Introduced
- 2021-06-23
- Latest action
- 2021-06-24 · Referred to the Subcommittee on Health.
Summary
Reducing Hereditary Cancer Act of 2021
This bill provides for Medicare coverage of germline mutation testing for individuals with a personal or family history of a hereditary cancer gene mutation or suspected history of hereditary cancer, as well as for associated coverage of risk-reducing surgeries and screenings.